Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $23.6 million.

  • Rhythm Pharmaceuticals' Prepaid Assets rose 16981.71% to $23.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 16981.71%. This contributed to the annual value of $16.4 million for FY2024, which is 8342.85% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Prepaid Assets of $23.6 million as of Q3 2025, which was up 16981.71% from $24.7 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Prepaid Assets high stood at $24.7 million for Q2 2025, and its period low was $7.3 million during Q3 2021.
  • In the last 5 years, Rhythm Pharmaceuticals' Prepaid Assets had a median value of $10.8 million in 2022 and averaged $12.2 million.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Prepaid Assets plummeted by 2924.49% in 2021, and later soared by 18523.83% in 2025.
  • Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Prepaid Assets stood at $12.4 million in 2021, then dropped by 4.75% to $11.8 million in 2022, then decreased by 24.36% to $8.9 million in 2023, then surged by 83.43% to $16.4 million in 2024, then soared by 44.12% to $23.6 million in 2025.
  • Its last three reported values are $23.6 million in Q3 2025, $24.7 million for Q2 2025, and $17.7 million during Q1 2025.